|[February 22, 2013]
Research and Markets: Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/bfklpn/radiopharmaceutica)
has announced the addition of the "Radiopharmaceuticals
Market - Global Industry Analysis, Size, Share, Trends And Forecast,
2012 - 2018" report to their offering.
Radiopharmaceuticals imply the usage of radiation for non-invasive
treatment and diagnosis of various diseases. Utilization of these
molecules for medical purposes in PET and SPECT imaging has changed the
entire algorithm of disease diagnosis. With rise in the aging population
globally coupled with increasing rate of chronic cardiovascular,
oncology and neurology diseases, there is tremendous growth potential in
this market, especially in developing nations. Similarly, the use of
radiolabeled isotopes with peptides and monoclonal antibodies has opened
new boulevards for the growth of the global radiopharmaceuticals market.
Many radiopharmaceuticals use technetium-99m (Tc-99m) that has many
useful properties of gamma-emitting tracer nuclide.
Radiopharmaceuticals are majorly used to diagnose cancer, tumors,
biliary tract blockage, bone diseases, bone marrow diseases, brain
diseases, colorectal disease, disorders of iron metabolismand
absorption, heart disease, heart muscle damage (infarct), impaired flow
of cerebrospinal fluid in the brain, kidney diseases, liver diseases,
lung diseases, parathyroid diseases, parathyroid cancer, pernicious
anemia, improper absorption of vitamin B12 from intestines, red blood
cell diseases, salivary gland diseases, spleen diseases, stomach and
intestinal bleeding, stomach problems, tear duct blockage, thyroid
diseases, thyroid cancer and urinary bladder diseases.
This may be given to the patient in a number of ways, for e.g. they may
be given through the mouth, through injections or placed into the eye or
into the bladder. It is a small treatment, which includes use of simple
substances containing radioactive isotopes. While treating cancer, these
radioactive agents are taken up in the cancerous area to destroy the
affected tissues. It works effectively by targeting the areas in the
body where the cancer is present. Individuals are suggested to intake
radiopharmaceuticals only under the direct supervision of a doctor.
This report analyses the global scenario of the radiopharmaceuticals
market, discussing detailed overview and market figures. The research
report analyses the industry growth rate, industry capacity, and
industry structure. The report analyses the historical data, and
forecasts the radiopharmaceuticals market size, production forecasts
along with key factors driving and restraining the market.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Global Radiopharmaceuticals Market Overview
Chapter 4 Market Definition & Supply Chain Analysis
Chapter 5 Global Radiopharmaceutical Generators Market
Chapter 6 Global Radiopharmaceuticals Market, By End-User Groups
Chapter 7 Global Radiopharmaceuticals Market, By Applications
Chapter 8 Global Radiopharmaceuticals Market, By Geography
Chapter 9 Market Share Analysis By Key Players
Chapter 10 Recommendations
Chapter 11 Company Profiles
- Cardinal Health Inc.
- Covidien Plc
- GE Healthcare
- IBA Group
- Lantheus Medical Imaging
- Monrol Nuclear Products, Inc.
- Nordion, Inc.
- NTP Radioisotopes (Pty) Ltd
- Positron Corporation
- Siemens (News - Alert) Healthcare
For more information visit http://www.researchandmarkets.com/research/bfklpn/radiopharmaceutica
[ Back To Technology News's Homepage ]